Clinical stage pharmaceutical company Cantex Pharmaceuticals has obtained a global licence from Harvard University’s Office of Technology Development to develop the small-molecule drug ...
KELOWNA, BC, Dec. 23, 2024 /CNW/ - Cantex Mine Development Corp. (TSXV: CD) (OTCQB: CTXDF) (the "Company") announces it has arranged and plans to close a $600,000 non ...
The Eastern Tombstone Belt in the Yukon and Northwest Territories is gaining momentum as Cantex Mine Development (TSXV: CD; OTCQB: CTXDF), Rackla Metals (TSXV: RAK), and Fireweed Metals (TSXV: FWZ;… ...
WESTON, Fla., Dec. 9, 2024 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life ...
KELOWNA, BC, Dec. 23, 2024 /CNW/ - Cantex Mine Development Corp. (TSXV: CD) (OTCQB: CTXDF) (the "Company") is pleased to announce that, further to its news release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results